Impax Asset Management Group plc Trims Stock Position in Stericycle, Inc. (NASDAQ:SRCL)

Impax Asset Management Group plc reduced its holdings in shares of Stericycle, Inc. (NASDAQ:SRCL - Free Report) by 6.4% in the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 2,925,141 shares of the business services provider's stock after selling 200,253 shares during the quarter. Impax Asset Management Group plc owned approximately 3.15% of Stericycle worth $168,597,000 as of its most recent filing with the SEC.

A number of other hedge funds have also made changes to their positions in the business. Pentwater Capital Management LP purchased a new position in shares of Stericycle during the second quarter worth about $83,010,000. Capital Research Global Investors lifted its stake in Stericycle by 13.4% in the fourth quarter. Capital Research Global Investors now owns 5,987,937 shares of the business services provider's stock valued at $296,762,000 after buying an additional 705,586 shares during the last quarter. Sei Investments Co. boosted its holdings in shares of Stericycle by 35.5% in the fourth quarter. Sei Investments Co. now owns 1,061,369 shares of the business services provider's stock valued at $52,601,000 after acquiring an additional 277,896 shares during the period. Earnest Partners LLC boosted its holdings in shares of Stericycle by 12.4% in the first quarter. Earnest Partners LLC now owns 2,460,020 shares of the business services provider's stock valued at $129,766,000 after acquiring an additional 271,025 shares during the period. Finally, Heartland Advisors Inc. grew its position in shares of Stericycle by 55.5% during the fourth quarter. Heartland Advisors Inc. now owns 583,545 shares of the business services provider's stock worth $29,733,000 after acquiring an additional 208,256 shares during the last quarter. Hedge funds and other institutional investors own 98.82% of the company's stock.

Stericycle Price Performance

SRCL stock traded up $2.70 on Friday, reaching $61.60. 13,788,054 shares of the company's stock were exchanged, compared to its average volume of 1,070,703. The stock has a fifty day moving average of $58.65 and a 200-day moving average of $54.13. The firm has a market cap of $5.72 billion, a PE ratio of -280.00, a P/E/G ratio of 3.23 and a beta of 1.11. The company has a quick ratio of 1.13, a current ratio of 1.13 and a debt-to-equity ratio of 0.55. Stericycle, Inc. has a twelve month low of $37.78 and a twelve month high of $61.71.

Stericycle (NASDAQ:SRCL - Get Free Report) last posted its quarterly earnings results on Thursday, July 25th. The business services provider reported $0.61 earnings per share for the quarter, topping analysts' consensus estimates of $0.57 by $0.04. Stericycle had a net margin of 1.37% and a return on equity of 7.94%. The business had revenue of $661.60 million for the quarter, compared to analysts' expectations of $672.07 million. As a group, equities analysts predict that Stericycle, Inc. will post 2.29 EPS for the current fiscal year.

Analysts Set New Price Targets

SRCL has been the subject of a number of recent research reports. Truist Financial increased their price target on shares of Stericycle from $50.00 to $62.00 and gave the stock a "hold" rating in a research note on Tuesday, June 4th. Keefe, Bruyette & Woods boosted their price target on Stericycle from $135.00 to $142.00 and gave the company an "outperform" rating in a research report on Tuesday, June 4th. Royal Bank of Canada reaffirmed a "sector perform" rating and set a $62.00 price objective (down from $69.00) on shares of Stericycle in a research report on Tuesday, June 4th. Finally, StockNews.com assumed coverage on Stericycle in a report on Sunday, September 1st. They issued a "hold" rating on the stock. One equities research analyst has rated the stock with a sell rating, four have issued a hold rating and two have given a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average target price of $74.00.

About Stericycle

Stericycle, Inc, together with its subsidiaries, provides regulated waste and compliance services in the United States, Europe, and internationally. The company offers regulated waste and compliance services, including regulated medical waste, sharps waste management and disposal, pharmaceutical waste management and disposal, chemotherapy waste and disposal, controlled substance waste disposal, healthcare hazardous waste, and integrated waste stream solutions; specialty services, such as MedDrop medication collection kiosks, safe community solutions, SafeDrop sharps mailback solutions, and airport and maritime waste services; medical supply store services, that includes sharps and disposable biohazardous waste containers, infection control supplies, and seal&send medication mail back; and compliance solutions including Steri-Safe compliance solutions.